AEON Biopharma, Inc.
USD0.75
+0.00 (+0.03%)
CEO
Robert Bancroft
IPO Date
2023-07-24
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Open
$0.73
Prev. Close
$0.75
Day Low
$0.73
Day High
$0.79
52W Low
$0.57
52W High
$1.45
Market Cap
$0.01B
Volume
0.02M
| 0 |
| $0.00 |
| 11 Mar 2026 | Oh Chad | CHIEF MEDICAL OFFICER | A-Award | Acquired | 862,500 | $0.00 |
| 11 Mar 2026 | Oh Chad | CHIEF MEDICAL OFFICER | A-Award | Acquired | 1,316,872 | $0.00 |
| 5 Mar 2026 | Wilson Alexander Blair | CLO, CSO, and Corp Secretary | A-Award | Acquired | 862,500 | $0.00 |
| 5 Mar 2026 | Wilson Alexander Blair | CLO, CSO, and Corp Secretary | A-Award | Acquired | 1,316,872 | $0.00 |
| 5 Mar 2026 | Sy Jennifer | PRINCIPAL ACCOUNTING OFFICER | A-Award | Acquired | 575,000 | $0.00 |
| 5 Mar 2026 | Sy Jennifer | PRINCIPAL ACCOUNTING OFFICER | A-Award | Acquired | 925,925 | $0.00 |
| 19 Feb 2026 | Bancroft Robert E. | director, officer: PRESIDENT & CEO | A-Award | Acquired | 3,000,000 | $0.00 |
| 29 Jan 2026 | Daewoong Co., Ltd | 10 percent owner | Disposed | 0 | $0.00 |